Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced that three abstracts will be presented at the San Antonio Breast Cancer ...

High-throughput technologies have produced vast multi-omics datasets (genomics, transcriptomics, epigenomics, proteomics) from large cancer initiatives such ...